Welcome to Mesothelioma-Line.com, your source for mesothelioma cancer journal articles.
Why look at mesothelioma journal articles?
The first indication you have mesothelioma often comes from your primary care physician or local oncologist, doctors who may have seen one other case of meso, if that. They are not aware of the variety, breadth, and depth of medical research and literature. Nor are they aware of the physicians, oncologists, and other mesothelioma specialists who work daily with mesothelioma patients, helping to extend lives and improve patients' quality of life.
Becoming an informed patient and taking an active roll in your treatment can not only help you find novel and effective treatment options, but also provide a sense of empowerment and control over your health.
A mesothelioma diagnosis is so heartbreaking because it is often delivered with hopelessness. There is hope.
Whether you're a patient, or a relative doing research, Mesothelioma-Line.com aims to provide a thorough reference point for academic journal articles on malignant mesothelioma organized in a manner useful to the specific needs of mesothelioma patients. Because of our focus, we try to keep the the articles limited to those dealing specifically with mesothelioma and asbestos. However, many other types of cancer, treatments, and general health articles are likely to be of use to you, so you may wish to also utilize PubMed.gov in your research. From their site:
PubMed is a service of the U.S. National Library of Medicine that includes over 16 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.
Using this site
All types of mesothelioma are represented in these articles, and while the information in any may be of use to you, we've also done our best to break down the articles based on categories like malignant pleural mesothelioma or malignant peritoneal mesothelioma. If you see an article that doesn't look right, or seems like it should belong to additional categories, fill out the comments at the end of the article or our contact form and let us know!
The information included on each page is simply the abstract of the article—usually a brief summation of the goal, procedures, results, and conclusions—and a glossary of terms found in the abstract.
Because the conclusion is often the part lay-people find most useful and comprehensible, our listings reflect this. The excerpt below each journal article title on the home, annual archives, individual category pages, and search results are either the conclusions (if noted in the abstract by "Conclusions:" or something similar) or simply the last two sentences of the abstract.
After each abstract is a glossary of terms based on the text to make it easier to understand the information. You may also view the glossary in it's entirety at any time by selecting it from the right-hand menu.
If you have suggestions on improvements, please let us know.
Want to learn more general information about mesothelioma cancer and/or asbestos?
Here are resources to learn more about a variety of asbestos, mesothelioma, and lung cancer-related issues. If you're unable to find the information you need, please let us know and we'll be happy to try and help.
- Mesothelioma cancer & asbestos related disease : Learn more about the causes, complicating factors, and latest news about pleural mesothelioma, asbestos-related lung cancer, peritoneal mesothelioma, and asbestos.
- Asbestos Attorneys: Mesothelioma lawyers who specialize in defending the rights of those injured by asbestos. Your job is to focus on your health, let someone else deal with the litigation.
- Browse journal articles by category to find information on the medications, procedures, symptoms and more. View the category page to find descriptions of many of the categories.
- Tags can further assist you in finding journal articles that match your topic or area of interest.
- Comments and trackbacks are closed, but please feel free to contact us with your questions, comments or inquiries.